Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:22

RNS Number : 0199K
Softcat PLC
05 April 2018
 

Softcat plc (the "Company")

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities

 

 

The following notification relates to the award of nil-cost options to person discharging managerial responsibilities ("PDMR") on 4 April 2018 under the Softcat plc Long Term Incentive Plan ("LTIP").  

 

Softcat plc Long Term Incentive Plan

 

On 4 April 2018, an award of nil-cost options to acquire 66,864 shares was made to Graeme Watt, a director and PDMR. The number of shares over which the nil-cost option was awarded has been calculated by reference to the closing middle market quotation of the ordinary shares derived from the Daily Official List on the dealing day preceding the date of grant (6.73 pence). The award will vest subject to the performance conditions outlined below.

 

 

Performance Conditions and Vesting of Awards

 

These nil-cost options are subject to the rules of the LTIP and will vest depending on performance against Total Shareholder Return ("TSR") and Earnings per Share ("EPS") targets as measured over a three year performance period.

 

50% of the Award will be subject to the Company's relative TSR performance against the FTSE 250 (excluding real estate and investment trusts):

 

TSR performance % of Award vesting

Below median Nil

At median 30%

Upper quartile or above 100%

 

50% of the Award will be subject to the Company's EPS for FY 2020:

 

EPS Growth % of Award vesting

Less than 23.7 pence Nil

23.7 pence 20%

26.9 pence or above 100%

 

There will be straight line vesting between the points as outlined above.

 

The normal date of vesting for the nil-cost options outlined above will be 4 April 2021 and the last date for exercise will be 3 April 2028, with dividend equivalents payable in respect of the vesting of nil-cost options in accordance with the rules of the LTIP.

 

For further information on the LTIP, please refer to the Company's Annual Report and Accounts.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graeme Watt

 

2.

Reason for the notification

a)

Position / status

Chief Executive

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Softcat plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.0005 each

 

 

ISIN: GB00BYZDVK82

b)

Nature of the transaction

Grant of nil cost option over Ordinary Shares of £0.0005 each under the Softcat plc Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.00

66,864

d)

Aggregated information

Aggregated volume

Price

 

N/A

e)

Date of the transaction

 

2018-04-04

f)

Place of the transaction

 

Outside a trading venue

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGDKKGGRZM
Date   Source Headline
12th Jun 201910:55 amRNSDirector/PDMR Shareholding
12th Jun 201910:52 amRNSDirector/PDMR Shareholding
12th Jun 201910:50 amRNSDirector/PDMR Shareholding
28th May 20197:12 amRNSBoard changes
20th May 20197:00 amRNSQ3 2019 Trading Update
10th May 20199:01 amRNSDirector/PDMR Shareholding
10th May 20198:58 amRNSDirector/PDMR Shareholding
10th Apr 201911:52 amRNSDirector/PDMR Shareholding
25th Mar 20199:21 amRNSDirector/PDMR Shareholding
21st Mar 201910:28 amRNSDirector/PDMR Shareholding
21st Mar 201910:27 amRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSHalf-year Report
8th Mar 20191:12 pmRNSDirector/PDMR Shareholding
1st Mar 201910:53 amRNSTotal Voting Rights
21st Feb 201910:00 amRNSNotice of Results
8th Feb 20194:57 pmRNSDirector/PDMR Shareholding
1st Feb 20191:58 pmRNSTotal Voting Rights
31st Jan 20199:10 amRNSAdditional Listing of Shares and PDMR Shareholding
30th Jan 20194:36 pmRNSDirector/PDMR Shareholding
30th Jan 20194:36 pmRNSHolding(s) in Company
16th Jan 20192:16 pmRNSHolding(s) in Company
16th Jan 20192:04 pmRNSAdditional Listing of Shares and PDMR Shareholding
9th Jan 20192:48 pmRNSDirector/PDMR Shareholding
9th Jan 20197:00 amRNSTrading Update
11th Dec 20182:48 pmRNSDirector/PDMR Shareholding
6th Dec 20184:30 pmRNSResult of AGM
28th Nov 20187:00 amRNSQ1 2019 Trading Update
26th Nov 20184:10 pmRNSDirector/PDMR Shareholding
26th Nov 20184:09 pmRNSDirector/PDMR Shareholding
26th Nov 20183:51 pmRNSDirector/PDMR Shareholding
12th Nov 20189:09 amRNSDirector/PDMR Shareholding
2nd Nov 201812:07 pmRNSAnnual Financial Report
17th Oct 20187:00 amRNSFinal Results
10th Oct 20184:57 pmRNSDirector/PDMR Shareholding
12th Sep 201810:23 amRNSDirector/PDMR Shareholding
10th Aug 20182:29 pmRNSDirector/PDMR Shareholding
11th Jul 20183:51 pmRNSDirector/PDMR Shareholding
11th Jul 201811:09 amRNSDirector/PDMR Shareholding
10th Jul 20187:00 amRNSTrading Statement
3rd Jul 20184:56 pmRNSHolding(s) in Company
12th Jun 201810:35 amRNSDirector/PDMR Shareholding
23rd May 20187:00 amRNSQ3 2018 Trading Update
10th May 20183:58 pmRNSDirector/PDMR Shareholding
30th Apr 20181:09 pmRNSTotal Voting Rights
12th Apr 201810:01 amRNSDirector/PDMR Shareholding
11th Apr 20182:41 pmRNSAdditional Listing of Shares and PDMR Shareholding
5th Apr 20184:22 pmRNSDirector/PDMR Shareholding
28th Mar 20185:53 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHalf-year Report
9th Mar 20183:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.